Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma

Key Points

• This review aims to explore the relationship between biologics and cutaneous pseudolymphomas, emphasizing a specific case of brodalumab.
• Conducted a narrative review of literature on biologic-induced cutaneous pseudolymphomas.
• Illustrated findings with a case study of brodalumab-induced pseudolymphoma in a psoriasis patient.
• Summarized various cases and mechanisms of biologic-induced pseudolymphomas.
• Presented the first known case of brodalumab leading to pseudolymphoma in psoriasis.